title: The Palliative-Supportive Care Unit in a Comprehensive Cancer Center as Crossroad for Patients' Oncological Pathway.
abstract: OBJECTIVE
  The aim of this study was to assess how an admission to an acute palliative-supportive care unit (APSCU), may influence the therapeutic trajectory of advanced cancer patients.
  
  
  METHODS
  A consecutive sample of advanced cancer patients admitted to APCU was assessed. The following parameters were collected: patients demographics, including age, gender, primary diagnosis, marital status, and educational level, performance status and reasons for and kind of admission, data about care-givers, recent anticancer treatments, being on/off treatment or uncertain, the previous care setting, who proposed the admission to APSCU. Physical and psychological symptoms were evaluated at admission and at time of discharge. The use of opioids was also recorded. Hospital staying was also recorded. At time of discharge the parameters were recorded and a follow-up was performed one month after discharge.
  
  
  RESULTS
  314 consecutive patients admitted to the APSCU were surveyed. Pain was the most frequent reason for admission. Changes of ESAS were highly significant, as well as the use of opioids and breakthrough pain medications (p <0.0005). A significant decrease of the number of "on therapy" patients was reported, and concomitantly a significant number of "off-therapy" patients increased. At one month follow-up, 38.9% patients were at home, 19.7% patients were receiving palliative home care, and 1.6% patients were in hospice. 68.5% of patients were still living.
  
  
  CONCLUSIONS
  Data of this study suggest that the APSCU may have a relevant role for managing the therapeutic trajectory of advanced cancer patients, limiting the risk of futile and aggressive treatment while providing an appropriate care setting.
authors.affiliation: Anesthesia and Intensive Care Unit and Supportive-Palliative Care Unit, La Maddalena Cancer Center, Palermo, Italy.
authors.forename: Sebastiano
authors.initials: S
authors.lastname: Mercadante
authors.affiliation: Anesthesia and Intensive Care Unit and Supportive-Palliative Care Unit, La Maddalena Cancer Center, Palermo, Italy.
authors.forename: Claudio
authors.initials: C
authors.lastname: Adile
authors.affiliation: Home Care program, SAMO, Palermo, Italy.
authors.forename: Amanda
authors.initials: A
authors.lastname: Caruselli
authors.affiliation: Anesthesia and Intensive Care Unit and Supportive-Palliative Care Unit, La Maddalena Cancer Center, Palermo, Italy.
authors.forename: Patrizia
authors.initials: P
authors.lastname: Ferrera
authors.affiliation: Department of Oncology, Hospital Sant'Andrea, University of Rome, Rome, Italy.
authors.forename: Andrea
authors.initials: A
authors.lastname: Costanzi
authors.affiliation: Department of Oncology, Hospital Sant'Andrea, University of Rome, Rome, Italy.
authors.forename: Paolo
authors.initials: P
authors.lastname: Marchetti
authors.affiliation: Department of Experimental Biomedicine and Clinical Neuroscience, University of Palermo, Palermo, Italy.
authors.forename: Alessandra
authors.initials: A
authors.lastname: Casuccio
mesh_terms: D000368:Aged; D000700:Analgesics / Q000627:therapeutic use; D002173:Cancer Care Facilities; D019091:Critical Pathways; D005260:Female; D005500:Follow-Up Studies; D006760:Hospitalization; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000628:therapy*; D010166:Palliative Care; D010351:Patient Discharge; D010359:Patient Readmission
chemical_list: D000700:Analgesics